Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Roche Holding Ltd (OP: RHHVF ) 314.25 +0.34 (+0.11%) Streaming Delayed Price Updated: 2:07 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Roche Holding Ltd < Previous 1 2 3 4 5 6 7 Next > EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody April 13, 2023 The FDA has granted Fast Track designation for SAB Biotherapeutics' (NASDAQ: SABS) SAB-176, an investigational therapeutic for Type A and Type B influenza illness in high-risk patients, including those... Via Benzinga New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients March 20, 2023 Via Benzinga FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting March 09, 2023 Via Benzinga Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo March 03, 2023 Via Benzinga Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines February 23, 2023 Via Benzinga New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder February 10, 2023 Via Benzinga Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition February 07, 2023 Via Benzinga Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics February 02, 2023 Via Benzinga Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer January 19, 2023 Via Benzinga Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism January 12, 2023 Via Benzinga Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review January 06, 2023 Via Benzinga Roche's Follicular Lymphoma Therapy Scores FDA Approval December 23, 2022 Via Benzinga FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment December 22, 2022 Via Benzinga Roche Presents New Data Demonstrating Potential Benefit Of Two Lymphoma Candidates December 12, 2022 Via Benzinga After 16 Years, Roche's Pharma Division Head Decides To Step Down December 12, 2022 Via Benzinga Replimune Shares Surge After Early Data From Pretreated Melanoma Patients December 07, 2022 Via Benzinga Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says November 16, 2022 Via Benzinga FDA Gives Emergency Use Nod To Roche's Monkeypox Test November 16, 2022 Via Benzinga Successful Alzheimer's Data Would Have Placed Roche At Two-Year Competitive Advantage November 15, 2022 Via Benzinga Roche Inks Second Drug Discovery Deal With Jnana Therapeutics November 15, 2022 Via Benzinga Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers November 14, 2022 Via Benzinga Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months November 14, 2022 Via Benzinga Roche Posts Lower Quarterly Sales As Demand For COVID Products Slide October 18, 2022 Via Benzinga Roche's Muscular Atrophy Treatment Improves Motor Function In Pretreated Patients October 12, 2022 Via Benzinga Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests October 12, 2022 Via Benzinga EXCLUSIVE: Lineage Cell Establishes New R&D Facility In US, Expands Israel-Based Facility October 03, 2022 Lineage Cell Therapeutics Inc (NYSE: LCTX) has opened a new research and development facility in Carlsbad, California. Via Benzinga FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests September 27, 2022 Via Benzinga COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns September 23, 2022 The World Health Organization (WHO) warned that it struggles to identify and Via Benzinga Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders September 19, 2022 Via Benzinga WHO Recommends Against Roche, GSK's COVID-19 Therapies Rendering Them Obsolete September 16, 2022 Due to the lack of effectiveness against omicron and the variants, World Health Organization (WHO) no longer recommends using two COVID-19 antibody therapies. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.